New lupus drug shows promise in early safety trial
NCT ID NCT04128579
First seen Jun 06, 2026 · Last updated Jun 16, 2026 · Updated 2 times
Summary
This early-stage study tested a drug called itolizumab (EQ001) in 52 adults with lupus, some of whom also had active kidney disease. The main goal was to check the drug's safety and how the body processes it. Researchers also looked at how the drug attaches to immune cells to better understand its effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AKDHC Medical Research Services, LLC
Sun City, Arizona, 85351, United States
-
Albert Einstein College of Medicine, Montefiore Medical Center
The Bronx, New York, 10461, United States
-
California Institute of Renal Research
Chula Vista, California, 91910, United States
-
Centre for Rheumatology, Immunology and Arthritis
Fort Lauderdale, Florida, 33309, United States
-
Clinical Research of West Florida - Clearwater
Clearwater, Florida, 33765-2616, United States
-
Clinical Research of West Florida - Tampa
Tampa, Florida, 33603, United States
-
Clinical Site Partners Leesburg, LLC
Leesburg, Florida, 34748, United States
-
Columbia University Medical Center, Div of Nephrology
New York, New York, 10032, United States
-
Dallas Renal Group
Dallas, Texas, 75230, United States
-
Georgia Nephrology
Lawrenceville, Georgia, 30046, United States
-
Hope Clinical Trials
Miami, Florida, 33165, United States
-
Jawaharlal Nehru Institute of Postgraduate Medical Education and Research (JIPMER)
Puducherry, India
-
MAX Super Specialty Hospital
New Delhi, India
-
Medanta - The Medicity Hospital
Gurugramam, India
-
Miedzyleski Szpital Specjalistyczny w Warszawie, Oddzial Nefrologiczny i Stacja Dializ
Warsaw, 04-749, Poland
-
Northeast Clinical Research Center, LLC
Bethlehem, Pennsylvania, 18017, United States
-
Northwell Health / Division of Rheumatology
Great Neck, New York, 11021, United States
-
Omega Research Maitland, LLC
Orlando, Florida, 32810, United States
-
Post Graduate Institute of Medical Education and Research (PGIMER)
Chandigarh, India
-
Prolato Clinical Research Center (PCRC)
Houston, Texas, 77054, United States
-
SP ZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi, Klinika Nefrologii, Hipertensjologii
Lodz, 92-213, Poland
-
SouthCoast Research Center Inc
Miami, Florida, 33136, United States
-
University of California San Diego Perlman Ambulatory Clinic
La Jolla, California, 92037, United States
-
University of Florida, Division of Rheumatology
Gainesville, Florida, 32610, United States
-
University of South Florida
Tampa, Florida, 33606, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.